Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers
| Autor: | Davis, John, Hackman, Frances, Ndongo, Marie-Noella, Choo, HengWee, Lewis, Drew, Tawadrous, Margaret, Goodrich, James, Langdon, Grant |
|---|---|
| Zdroj: | In Clinical Therapeutics 2010 32(11):1889-1895 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect